Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research ...
Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...
Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these ...
The study introduces a three-circle convergence framework, AI, smart functionality and sustainability, demonstrating that the ...
An AI-driven computational toolkit, Gcoupler, integrates ligand design, statistical modeling, and graph neural networks to predict endogenous metabolites that allosterically modulate the GPCR–Gα ...
Global healthcare giant Abbott is recalling faulty blood glucose sensors across multiple countries due to potentially ...
A new study reveals that diabetes and weight loss drugs known as GLP-1s are lined with an increased risk of a chronic ...
Rocket Pharmaceuticals (NASDAQ:RCKT) advances gene-therapy innovation and appears in broader discussions involving the nasdaq ...
Objective overview of Candel Therapeutics within the biotechnology sector, highlighting developmental activity and scientific ...
The universal features that define genomic regions acting as replication origins remain unclear. In this study, we mapped a set of origins in Trypanosoma brucei using stranded short nascent strand ...
Background CFTR modulators have transformed cystic fibrosis (CF) treatment, but individual responses vary even among patients with identical CFTR genotypes. This underscores the need for predictive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback